Benzinga | Sep 7, 2021 07:50AM EDT

Exane BNP Paribas Downgrades Lam Research to Neutral, Announces $640 Price Target

Exane BNP Paribas analyst Jerome Ramel downgrades Lam Research (NASDAQ:LRCX) from Outperform to Neutral and announces $640 price target.